- Credit Suisse 31st Annual Healthcare Conference 2022: November 8th, 8:35amPT/11:35amET, in Rancho Palos Verdes, CA
- 13th Annual Jefferies Global Healthcare Conference 2022: November 16th, 8:35amGMT, in London, England
SAN RAFAEL, Calif., Nov. 3, 2022 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will present at two upcoming investor conferences. To access the live webcasts, please visit: https://investors.biomarin.com/. An archived version of the presentations will also be available through the Company's website for a limited time following the conference.
About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates.
For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.
Contacts: |
|
Investors |
Media |
Traci McCarty |
Debra Charlesworth |
BioMarin Pharmaceutical Inc. |
BioMarin Pharmaceutical Inc. |
(415) 455-7558 |
415) 455-7451 |
SOURCE BioMarin Pharmaceutical Inc.
![](https://rt.prnewswire.com/rt.gif?NewsItemId=SF24281&Transmission_Id=202211030830PR_NEWS_USPR_____SF24281&DateId=20221103)
Share this article